MedTrace Logo

REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension

NCT07780500 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-08-21

No results posted yet for this study

Summary

The goal of the REFOCUS-HTN US-WEST program is to gain a better understanding of the role of a hormone called aldosterone in the development of hypertension. The SCALED sub-study is an observational cohort study that will enroll from REFOCUS-HTN cohort for prospective data collection.

Conditions

  • Hypertension
  • Aldosterone Disorder
  • Cardiovascular Disease (CVD)

Interventions

OTHER

observational study

Participants are not assigned an intervention

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-20
Primary Completion
2028-03-31
Completion
2029-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07780500 on ClinicalTrials.gov